Search - tctmd.com

Displaying 81 - 100 of 289

Sort: Relevancy | Date

Presentation TCT 2019

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Presenter: Eric Secemsky

September 27, 2019

Presentation TCT 2019

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

Presenter: Daizo Kawasaki

September 26, 2019

Presentation TCT 2019

New Crossing Techniques for Complex Femoropopliteal Disease

Presenter: Makoto Utsunomiya

September 26, 2019

Presentation TCT 2019

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Presenter: Yoshimitsu Soga

September 26, 2019

Presentation TCT 2019

Updates and Technique of Percutaneous Transvenous Arterial Femoral Popliteal Bypass Procedure

Presenter: Steve Henao

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

Presenter: Lawrence Garcia

September 25, 2019

Presentation TCT 2019

Can Baseline IVUS Predict Dissection Patterns of Femoropopliteal Lesions?

Presenter: Daizo Kawasaki

September 25, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Todd Neale

August 07, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Todd Neale

June 17, 2019

Advertisement

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

New Crossing Techniques for Complex Femoropopliteal Disease

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Updates and Technique of Percutaneous Transvenous Arterial Femoral Popliteal Bypass Procedure

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

Can Baseline IVUS Predict Dissection Patterns of Femoropopliteal Lesions?

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Microvascular Disease Quadruples Risk of Leg Amputation

TCTMD’s Top 10 Most Popular Stories for June 2019

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content